Drug Shortage Report for ESOMEPRAZOLE
| Report ID | 105868 |
| Drug Identification Number | 02431173 |
| Brand name | ESOMEPRAZOLE |
| Common or Proper name | ESOMEPRAZOLE |
| Company Name | SANIS HEALTH INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ESOMEPRAZOLE |
| Strength(s) | 40MG |
| Dosage form(s) | TABLET (DELAYED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | A02BC |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Shortage of an inactive ingredient or component. |
| Anticipated start date | 2020-03-26 |
| Actual start date | 2020-03-24 |
| Estimated end date | 2021-07-30 |
| Actual end date | 2021-08-03 |
| Shortage status | Resolved |
| Updated date | 2021-08-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2020-02-12 | English | Compare |